- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Klaria Pharma Holding AB (KLAR)
Klaria Pharma Holding AB stock price live, this page displays ST KLAR stock exchange data. View the KLAR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Klaria Pharma Holding AB real time stock price chart below.
What Is the Klaria Pharma Holding AB Stock Price Today?
The Klaria Pharma Holding AB stock price today is 0.467.
What Is the Stock Symbol for Klaria Pharma Holding AB?
The stock symbol for Klaria Pharma Holding AB is ""KLAR.""
What Stock Exchange Does Klaria Pharma Holding AB Trade On?
Klaria Pharma Holding AB is listed and trades on the Stockholm stock exchange.
Is Klaria Pharma Holding AB a Good Stock to Buy?
Determining whether Klaria Pharma Holding AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KLAR quote. (ISIN: SE0007280326)
What Is the Klaria Pharma Holding AB Stock Price Today?
The Klaria Pharma Holding AB stock price today is 0.467.
What Is the Stock Symbol for Klaria Pharma Holding AB?
The stock symbol for Klaria Pharma Holding AB is ""KLAR.""
What Stock Exchange Does Klaria Pharma Holding AB Trade On?
Klaria Pharma Holding AB is listed and trades on the Stockholm stock exchange.
Is Klaria Pharma Holding AB a Good Stock to Buy?
Determining whether Klaria Pharma Holding AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KLAR quote. (ISIN: SE0007280326)
Stockholm
Currency in SEK
0.467
-0.032(-6.41%)
Closed·
Fair Value
An estimate of a Klaria Pharma Holding AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.449
0.499
52 wk Range
0.282
1.810
KLAR Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a Klaria Pharma Holding AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.4490.499
52 wk Range
0.2821.810
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KLAR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Klaria Pharma Holding AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Klaria Pharma Holding AB Company Profile
Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock. Its product pipeline includes Sumatriptan, a novel the treatment of migraine which is in final stage of approval; Epinephrine/Adrenaline which is in Phase I clinical trial for the treatment of acute allergic reaction; and Sirolimus which is in pre-clinical stage for prevention of organ transplant rejection. The company is also involved in commercialization and sale of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquartered in Uppsala, Sweden.
Compare KLAR to Peers and Sector
Metrics to compare | KLAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKLARPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.0x | 0.0x | −0.5x | |
PEG Ratio | −0.10 | 0.00 | 0.00 | |
Price/Book | 67.2x | 0.0x | 2.6x | |
Price / LTM Sales | 10.2x | 0.0x | 3.3x | |
Upside (Analyst Target) | 114.1% | 0.0% | 40.6% | |
Fair Value Upside | Unlock | 0.0% | 5.3% | Unlock |
Earnings
Latest Release
May 21, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
8.99M / --
FAQ
What Stock Exchange Does Klaria Pharma Holding AB Trade On?
Klaria Pharma Holding AB is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Klaria Pharma Holding AB?
The stock symbol for Klaria Pharma Holding AB is "KLAR."
What Is the Klaria Pharma Holding AB Market Cap?
As of today, Klaria Pharma Holding AB market cap is 114.87M.
What Is Klaria Pharma Holding AB's Earnings Per Share (TTM)?
The Klaria Pharma Holding AB EPS (TTM) is -0.28.
When Is the Next Klaria Pharma Holding AB Earnings Date?
Klaria Pharma Holding AB will release its next earnings report on 27 Aug 2025.
From a Technical Analysis Perspective, Is KLAR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Klaria Pharma Holding AB Stock Split?
Klaria Pharma Holding AB has split 0 times.
How Many Employees Does Klaria Pharma Holding AB Have?
Klaria Pharma Holding AB has 4 employees.
What is the current trading status of Klaria Pharma Holding AB (KLAR)?
As of 15 Aug 2025, Klaria Pharma Holding AB (KLAR) is trading at a price of 0.47, with a previous close of 0.47. The stock has fluctuated within a day range of 0.45 to 0.50, while its 52-week range spans from 0.28 to 1.81.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.